Battle Lines Clear On Conflict Of Interest Policy In PDUFA Reauthorization
By
Derrick Gingery / Email the Author / “The Tan Sheet” Feb. 20, 2012, Vol. 20, No. 08
FDA / Word Count: 1224 / Article # 05120213002
Executive Summary
Commissioner Hamburg says the agency likely does not need legislation to improve its conflict of interest policy, but House members still say the system needs reform. Industry and patient advocate groups push for change, while consumer groups press FDA to stand firm.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.